Contact & Business Details
📱 WhatsApp : +91-9359256675 (🔥 Best Offer – Order on WhatsApp & Save More! 🔥)
💬 WhatsApp Link : https://wa.me/+919359256675
📧 Email : sales@medswalapharmacy.com
🌐 Website: https://www.indiamedicineexporter.com/
Tislelizumab injection 100mg/10mL, marketed under the brand name Tevimbra, is an advanced oncology immunotherapy medicine containing tislelizumab, a monoclonal antibody that targets the programmed cell death protein 1 (PD-1). It belongs to the immune checkpoint inhibitor class of medicines and is used for specific cancer indications according to the approved prescribing information in each country. For pharmaceutical procurement teams, hospitals, licensed distributors, and qualified international buyers, product identification, approved documentation, storage requirements, and regulatory compliance are important considerations when sourcing oncology medicines. Medswala Pharmacy India focuses on pharmaceutical product sourcing and international B2B supply enquiries for eligible global markets, subject to applicable export and import regulations.
🔬 What Is Tislelizumab (Tevimbra) Injection?
Tislelizumab is a humanised monoclonal antibody designed to block PD-1, a protein involved in regulating immune responses. By blocking this pathway, tislelizumab can help the immune system recognise and attack certain cancer cells. Tevimbra is supplied as a concentrate for intravenous infusion. The 100mg/10mL presentation contains 100mg of tislelizumab in a 10mL vial, equivalent to a concentration of 10mg/mL. The medicine is intended for administration by qualified healthcare professionals in an appropriate clinical setting. Treatment selection, dosing, infusion preparation, and monitoring must follow the locally approved product information and the treating oncologist’s instructions.
🏥 Tislelizumab Uses and Oncology Applications
Depending on the country-specific product approval, tislelizumab may be indicated for selected cancer treatments, including:
- Esophageal squamous cell carcinoma (ESCC)
- Gastric cancer and gastroesophageal junction adenocarcinoma
- Non-small cell lung cancer (NSCLC)
- Other approved oncology indications in specific jurisdictions
Approved indications, biomarker requirements, treatment combinations, and eligibility criteria vary between countries. Always consult the current local prescribing information before making treatment-related decisions.
📦 Tislelizumab 100mg/10mL Product Specifications
- Generic name: Tislelizumab
- Brand name: Tevimbra
- Strength: 100mg/10mL
- Concentration: 10mg/mL
- Dosage form: Concentrate for solution for intravenous infusion
- Therapeutic category: Oncology / Immunotherapy / PD-1 checkpoint inhibitor
- Supply format: Single-dose vial, subject to the specific approved presentation
- Storage: Follow the product label and approved handling requirements
🌐 Tislelizumab Injection Supplier and Export Enquiries from India
Medswala Pharmacy India welcomes qualified B2B pharmaceutical sourcing enquiries for oncology products. Buyers can enquire about product availability, manufacturer and brand details, batch documentation, applicable regulatory documents, shipping feasibility, and market-specific import requirements. International pharmaceutical procurement requires careful verification of product authenticity, supplier authorisation, cold-chain requirements where applicable, and import permissions. Availability and export eligibility should be confirmed before an order is placed.
Why Work with Medswala Pharmacy India?
✅ Pharmaceutical product sourcing enquiries
✅ B2B communication for qualified international buyers
✅ Product and documentation verification enquiries
✅ Support with export-related coordination, where permitted
✅ International supply enquiries subject to local regulations
✅ Product availability confirmation before order processing
🌎 International Pharmaceutical Markets
Medswala Pharmacy India receives enquiries relating to international pharmaceutical sourcing and export opportunities. Potential destination markets may include the United States, United Kingdom, Australia, Singapore, Japan, South Korea, Thailand, the Philippines, Chile, and other eligible markets. Supply of tislelizumab or any other prescription oncology medicine is subject to the product's registration status, applicable export authorisations, local import laws, and any required cold-chain and distribution controls in the destination country. Availability to a particular country is not guaranteed.
🌍 Countries We Export To | Global Pharmaceutical Supply from India
Medswala Pharmacy India – Global Pharmaceutical Exporter from India, welcomes international B2B pharmaceutical sourcing enquiries from eligible markets worldwide. We aim to connect qualified pharmaceutical importers, licensed distributors, hospitals, and healthcare procurement organisations with pharmaceutical supply opportunities, subject to applicable regulations and product availability.
🇺🇸 Pharmaceutical Export to the United States
We welcome pharmaceutical sourcing enquiries from the United States, including New York, Los Angeles, Chicago, Houston, Dallas, San Antonio, Atlanta, Denver, Orlando, Boston, Philadelphia, Phoenix, Las Vegas, Baltimore, Sacramento, Kansas City, Columbus, Indianapolis, Miami, San Francisco, Jacksonville, and Raleigh.
🇬🇧 Pharmaceutical Export to the United Kingdom
Our international sourcing enquiries include London, Manchester, Birmingham, Southampton, Belfast, Coventry, Aberdeen, Milton Keynes, Norwich, Cardiff, Leeds, and Newcastle.
🇦🇺 Pharmaceutical Export to Australia
We welcome enquiries from Sydney, Melbourne, Brisbane, Perth, Adelaide, Gold Coast, Newcastle, Logan City, Rockhampton, Bundaberg, Townsville, Gladstone, Orange, and Mildura.
🇸🇬 Pharmaceutical Export to Singapore
We welcome B2B pharmaceutical sourcing enquiries from Singapore, including Ang Mo Kio, Serangoon, and Pasir Ris.
🌏 Other International Markets
We also welcome eligible pharmaceutical sourcing enquiries from:
- 🇯🇵 Japan
- 🇨🇱 Chile
- 🇰🇷 South Korea
- 🇹🇭 Thailand
- 🇵🇭 Philippines
📦 International Oncology Medicine Supply
For Tislelizumab (Tevimbra) Injection 100mg/10mL, international supply is subject to product registration, export authorisation, destination-country import requirements, applicable cold-chain controls, and verification of supplier and product documentation. Availability and delivery to individual destinations must be confirmed before an order is accepted.
❄️ Storage, Handling and Product Quality
Tislelizumab is a biological medicine requiring appropriate storage and handling. The approved product information should be followed for temperature control, transport, preparation, infusion, and disposal. Healthcare professionals should review the current product label for warnings, potential immune-mediated adverse reactions, infusion-related reactions, and monitoring requirements. This medicine should only be used under appropriate specialist medical supervision.
Contact & Business Details
📱 WhatsApp: +91-9359256675 (🔥 Best Offer – Order on WhatsApp & Save More! 🔥)
💬 WhatsApp Link : https://wa.me/+919359256675
📧 Email: sales@medswalapharmacy.com
🌐 Website: https://www.indiamedicineexporter.com/
